XRF Scientific is set to broaden its industrial reach by acquiring Bruker’s Combustion Gas Analysis business for USD 4 million, adding a profitable product line and new market sectors.
- Acquisition of Bruker’s CGA business for USD 4 million upfront plus earnout
- Production transfer from Germany to Perth planned by Q3 2026
- CGA business generated USD 5.3 million revenue in 2025 (unaudited)
- Expansion into diverse industries beyond mining
- Cross-selling opportunities with existing XRF products
Strategic Acquisition Broadens XRF’s Industrial Footprint
XRF Scientific (ASX:XRF) is poised to significantly expand its analytical instruments portfolio by acquiring Bruker AXS SE’s Combustion Gas Analysis (CGA) business for an upfront cash payment of USD 4 million, with an additional earnout of up to USD 1 million linked to future revenue. The deal, executed through XRF’s wholly owned subsidiary, will bring a profitable and complementary product range into XRF’s fold.
The CGA business, which produced unaudited revenues of USD 5.3 million in 2025, specialises in precision elemental analysis of carbon, sulfur, oxygen, hydrogen, and nitrogen. Its instruments serve a broad spectrum of industries, including steel production, cement manufacturing, glass and ceramics, nuclear materials, and additive manufacturing. This diversification marks a notable shift for XRF, historically focused on mining and construction materials sectors.
Operational Transition and Market Reach
Currently manufactured in Karlsruhe, Germany, the CGA product line’s production will be relocated to XRF’s Perth facility by the third quarter of 2026. The transition plan, supported by Bruker, aims for a seamless handover, with key sales and technical staff from Germany and the USA joining XRF to maintain product quality and customer support standards globally.
Revenue recognition for the CGA business is expected to commence in the fourth quarter of 2026, once production is fully transferred. The CGA sales network is global, with strong footprints in Europe, North America, and Asia, primarily through third-party distributors. XRF intends to sustain and expand these channels, leveraging its existing international distribution infrastructure.
This acquisition follows XRF’s recent momentum in international markets, highlighted by a 13.8% surge in March quarter revenue driven by strong overseas demand and the opening of a new office in India. Such developments reinforce XRF’s strategy to deepen its global presence and product offering, positioning the company for sustained growth in the analytical instruments space.
Financial and Strategic Implications
The upfront purchase price of USD 4 million is funded from XRF’s existing cash reserves, including approximately USD 0.8 million in inventory and demonstration instruments valued at cost. The earnout arrangement, capped at USD 1 million, is tied to 7% of net CGA revenues over three years, providing a performance-linked incentive that aligns with XRF’s growth ambitions.
Managing Director Vance Stazzonelli emphasised the strategic fit: "While the CGA product range is non-core to Bruker, it will form a material part of our business and future growth plans. We look forward to supporting existing CGA customers and their laboratory operations around the world." This acquisition opens cross-selling opportunities with XRF’s existing analytical instruments, such as the xrTGA and Labfit CS-1232, potentially enhancing revenue streams through consumables and service contracts.
Bruker’s President of the AXS Division, Frank Burgaezy, acknowledged the deal as a positive outcome for the CGA business, noting the alignment with XRF’s capabilities and long-standing partnership. The transition plan’s execution and integration will be key to realising the acquisition’s full potential.
Bottom Line?
XRF’s acquisition of Bruker’s CGA business diversifies its product line and industrial reach, but successful integration and market expansion will be critical to unlocking value.
Questions in the middle?
- How smoothly will the production transfer from Germany to Perth proceed without disrupting supply?
- Can XRF effectively leverage cross-selling opportunities to boost consumable revenues?
- What impact will the earnout structure have on XRF’s financial performance over the next three years?